Clinical Trial: Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma

Sponsor and Collaborators
Medical University of South Carolina
Genentech

Contact
Shanta Salzer
843-792-1463

Yubin Kang, MD
843-792-6520

Principal Investigator
Yubin Kang, MD
Medical University of South Carolina

ClinicalTrials.gov Identifier 
NCT01410981

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs